Apomorphine in the treatment of Parkinson's disease: a review

Apomorphine in the treatment of Parkinson's disease: a review

ABSTRACT Optimizing idiopathic Parkinson's disease treatment is a challenging, multifaceted and continuous process with direct impact on patients’ quality of life. The basic tenet of this task entails tailored therapy, allowing for optimal motor function with the fewest adverse effects. Apomorp...

Full description

Saved in:

Bibliographic Details
Main Authors:	Renata Ramina Pessoa, Adriana Moro, Renato Puppi Munhoz, Hélio A.G. Teive, Andrew J. Lees
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações
Series:	Arquivos de Neuro-Psiquiatria
Subjects:	Apomorphine dopaminer agents Parkinsons disease review
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018001200840&lng=en&tlng=en
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The prevalence of impulsive compulsive behaviors in patients treated with apomorphine infusion: a retrospective analysis
by: Pedro Barbosa, et al.
Published: (2021-11-01)

A Highly Potent Apomorphine Derivative Enhancing Neurite Outgrowth via Nrf2 Activation
by: Tamaki Ishima, et al.
Published: (2025-04-01)

Satisfaction and Preferences for Infusion Therapies in Advanced Parkinson’s Disease—Patient Perspective
by: Julia Węgrzynek-Gallina, et al.
Published: (2024-12-01)

Postural instability in Parkinson?s disease ? 120 years after Charcot?s death
by: Hélio Afonso Ghizoni Teive, et al.
Published: (2014-08-01)

Parkinson’s disease – 200 years: the outstanding contribution of “Old Hubert”
by: Hélio A. G. Teive, et al.

Impulsivity in Patients with Parkinson’s Disease
by: Rumyana Kuzmanova, et al.
Published: (2017-11-01)

Non-motor signs in Parkinson’s disease: a review
by: Renato P. Munhoz, et al.
Published: (2015-05-01)

Astaxanthin-loaded brain-permeable liposomes for Parkinson’s disease treatment via antioxidant and anti-inflammatory responses
by: Thai-Duong Nguyen, et al.
Published: (2025-02-01)

Vestibular rehabilitation: clinical benefits to patients with Parkinson's disease Reabilitação vestibular: utilidade clínica em pacientes com doença de Parkinson
by: Bianca Simone Zeigelboim, et al.
Published: (2009-06-01)

Small Molecules in Parkinson’s Disease Therapy: From Dopamine Pathways to New Emerging Targets
by: Hwayoung Lee, et al.
Published: (2024-12-01)

Intervention strategies for Parkinson’s disease: the role of exercise and mitochondria
by: Ganggang Xu, et al.
Published: (2025-05-01)

Neurodegeneration in Parkinson’s disease: are we looking at the right spot?
by: Gabriel S. Rocha, et al.
Published: (2025-08-01)

Charcot and vascular Parkinsonism
by: Hélio A. G. Teive, et al.

Pull test performance and correlation with falls risk in Parkinson?s disease
by: Renato P. Munhoz, et al.
Published: (2014-08-01)

Vascular parkinsonism showing dopamine transporter scan findings mimicking those of Parkinson's disease
by: Hirotaka Sakuramoto, et al.
Published: (2024-12-01)

Parkinson’s disease. Focus on early stages
by: E. A. Katunina, et al.
Published: (2023-07-01)

Early-onset Parkinson's disease and depression Doença de Parkinson de início precoce e depressão
by: Délcio Bertucci Filho, et al.
Published: (2007-03-01)

Unusual motor and non-motor symptoms and signs in the early stage of Parkinson’s disease
by: Hélio A. G. Teive, et al.

USE OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY-STAGE PARKINSON’S DISEASE: DESCRIPTION OF A CLINICAL CASE
by: N. V. Fedorova, et al.
Published: (2014-11-01)

Adropin exerts neuroprotection in an experimental rat model of Parkinson’s disease
by: Ayse Ozkan, et al.
Published: (2025-06-01)

Altered reactivity to threatening stimuli in Drosophila models of Parkinson’s disease, revealed by a trial-based assay
by: Márton Kajtor, et al.
Published: (2025-07-01)

Zona incerta: from Parkinson's disease to addiction
by: Mylène Wilt, et al.
Published: (2025-02-01)

Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson’s disease
by: Zachary Gaertner, et al.
Published: (2025-05-01)

Comparative Molecular Docking Studies of Selected Phytoconstituents on Adenosine A2A Receptor (PDB ID: 3UZA) as Potential Anti-Parkinson’s Agents
by: Namrata Kumari, et al.
Published: (2023-11-01)

Dopamine dysregulation syndrome in Parkinson's disease: case report Síndrome de desregulação dopaminérgica na doença de Parkinson: relato de caso
by: Arthur Kummer, et al.
Published: (2006-12-01)

O papel de Charcot na doença de Parkinson
by: HÉLIO A.G. TEIVE
Published: (1998-03-01)

Electrophysiologic characteristics of tremor in Parkinson?s disease and essential tremor
by: Ederson Cichaczewski, et al.
Published: (2014-04-01)

Genetically engineered BMSCs promote dopamine secretion and ameliorate motor dysfunction in a Parkinson’s disease rat model
by: Chunjing Wang, et al.
Published: (2025-04-01)

Levodopa induces thyroid function regulation in a patient with thyroid hormone resistance and Parkinson’s disease: a case report
by: Gabriela Rozo-Paz, et al.
Published: (2025-03-01)

The Parkinson's disease and restless legs syndrome/Willis-Ekbom disorder link: evidences, biases and clinical relevance
by: Renato Puppi Munhoz, et al.

Worsening of parkinsonism after the use of veralipride for treatment of menopause: case report
by: Helio A. G. Teive, et al.
Published: (2001-03-01)

Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease
by: Sang‐Min Oh, et al.
Published: (2015-03-01)

Combining QSAR and Molecular Docking for the Methodological Design of Novel Radiotracers Targeting Parkinson’s Disease
by: Juan A. Castillo-Garit, et al.
Published: (2025-07-01)

Inhibition of levodopa metabolism to dopamine by honokiol short-chain fatty acid derivatives may enhance therapeutic efficacy in Parkinson’s disease
by: Gang Cheng, et al.
Published: (2025-06-01)

D2 receptor antagonist raclopride regulates glutamatergic neuronal activity in the pedunculopontine nucleus in a rat model of Parkinson's disease
by: Hongli Chang, et al.
Published: (2024-12-01)

Cognitive function assessment in idiopathic Parkinson's disease Avaliação da função cognitiva em doença de Parkinson idiopática
by: Mauro R. Piovezan, et al.
Published: (2007-12-01)

Factitious disorder mimicking addiction to levodopa in a patient with advanced Parkinson's disease Transtorno factício mimetizando adição a levodopa em paciente com doença de Parkinson avançada
by: Antônio L. Teixeira-Jr, et al.
Published: (2005-06-01)

Targeted Liposomal Co-Delivery Dopamine with 3-n-Butylphthalide for Effective Against Parkinson’s Disease in Mice Model
by: Liang Y, et al.
Published: (2024-11-01)

Neuroimagem do transportador de dopamina na doença de Parkinson: primeiro estudo com [99mTc]-TRODAT-1 e SPECT no Brasil Neuroimaging of the dopamine transporter in Parkinson’s disease: first study using [99mTc]-TRODAT-1 and SPECT in Brazil
by: Ming Chi Shih, et al.
Published: (2006-09-01)

Professor Charles David Marsden
by: Hélio A.G. Teive, et al.
Published: (2009-06-01)